A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones

ObjectiveTo investigate the efficacy and safety of minimally invasive percutaneous nephrolithotomy (MPCNL) combined with ureteral access sheath in the treatment of complex kidney stones.MethodsSeventy patients with complex kidney stones in the author's hospital from June 2022 to December 2023 w...

Full description

Saved in:
Bibliographic Details
Main Authors: Boyang Liu, Yanjie Kang, Yafeng Shang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Surgery
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2025.1557603/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849731085369344000
author Boyang Liu
Boyang Liu
Yanjie Kang
Yafeng Shang
author_facet Boyang Liu
Boyang Liu
Yanjie Kang
Yafeng Shang
author_sort Boyang Liu
collection DOAJ
description ObjectiveTo investigate the efficacy and safety of minimally invasive percutaneous nephrolithotomy (MPCNL) combined with ureteral access sheath in the treatment of complex kidney stones.MethodsSeventy patients with complex kidney stones in the author's hospital from June 2022 to December 2023 were randomized. There were 35 cases of minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath and 35 cases of minimally invasive percutaneous nephrolithotomy alone.ResultsCompared to the MPCNL group, the MPCNL + UAS group demonstrated a significantly shorter operative time (55.4 ± 9.2 min vs. 61.5 ± 12.8 min, p = 0.027), significantly lower intraoperative renal pelvic pressure (9.15 ± 4.13 mmHg vs. 11.35 ± 4.21 mmHg, p = 0.031), and a significantly lower incidence of postoperative Clavien complications (p < 0.05); however, there were no significant differences between the groups in postoperative creatinine change, stone clearance rate at 1 day postoperatively, or stone clearance rate at 30 days postoperatively (p > 0.05).ConclusionsMinimally invasive percutaneous nephrolithotomy combined with ureteral access sheath is safe and effective in the treatment of complex kidney stones. Ureteral access sheath can significantly shorten the operation time of minimally invasive PCNL, keep the visual field clear, reduce the pressure of renal pelvis, and reduce the incidence of complications.
format Article
id doaj-art-0bfa49f208a64ea4b76553f361b102c3
institution DOAJ
issn 2296-875X
language English
publishDate 2025-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Surgery
spelling doaj-art-0bfa49f208a64ea4b76553f361b102c32025-08-20T03:08:40ZengFrontiers Media S.A.Frontiers in Surgery2296-875X2025-07-011210.3389/fsurg.2025.15576031557603A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stonesBoyang Liu0Boyang Liu1Yanjie Kang2Yafeng Shang3Department of Urology, Xinxiang Medical University, Xinxiang, ChinaDepartment of Urology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, ChinaDepartment of Urology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, ChinaDepartment of Urology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, ChinaObjectiveTo investigate the efficacy and safety of minimally invasive percutaneous nephrolithotomy (MPCNL) combined with ureteral access sheath in the treatment of complex kidney stones.MethodsSeventy patients with complex kidney stones in the author's hospital from June 2022 to December 2023 were randomized. There were 35 cases of minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath and 35 cases of minimally invasive percutaneous nephrolithotomy alone.ResultsCompared to the MPCNL group, the MPCNL + UAS group demonstrated a significantly shorter operative time (55.4 ± 9.2 min vs. 61.5 ± 12.8 min, p = 0.027), significantly lower intraoperative renal pelvic pressure (9.15 ± 4.13 mmHg vs. 11.35 ± 4.21 mmHg, p = 0.031), and a significantly lower incidence of postoperative Clavien complications (p < 0.05); however, there were no significant differences between the groups in postoperative creatinine change, stone clearance rate at 1 day postoperatively, or stone clearance rate at 30 days postoperatively (p > 0.05).ConclusionsMinimally invasive percutaneous nephrolithotomy combined with ureteral access sheath is safe and effective in the treatment of complex kidney stones. Ureteral access sheath can significantly shorten the operation time of minimally invasive PCNL, keep the visual field clear, reduce the pressure of renal pelvis, and reduce the incidence of complications.https://www.frontiersin.org/articles/10.3389/fsurg.2025.1557603/fullMPCNLkidney stones (KSs)ureteral access sheathefficacysafety
spellingShingle Boyang Liu
Boyang Liu
Yanjie Kang
Yafeng Shang
A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones
Frontiers in Surgery
MPCNL
kidney stones (KSs)
ureteral access sheath
efficacy
safety
title A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones
title_full A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones
title_fullStr A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones
title_full_unstemmed A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones
title_short A clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones
title_sort clinical study on minimally invasive percutaneous nephrolithotomy combined with ureteral access sheath for the treatment of kidney stones
topic MPCNL
kidney stones (KSs)
ureteral access sheath
efficacy
safety
url https://www.frontiersin.org/articles/10.3389/fsurg.2025.1557603/full
work_keys_str_mv AT boyangliu aclinicalstudyonminimallyinvasivepercutaneousnephrolithotomycombinedwithureteralaccesssheathforthetreatmentofkidneystones
AT boyangliu aclinicalstudyonminimallyinvasivepercutaneousnephrolithotomycombinedwithureteralaccesssheathforthetreatmentofkidneystones
AT yanjiekang aclinicalstudyonminimallyinvasivepercutaneousnephrolithotomycombinedwithureteralaccesssheathforthetreatmentofkidneystones
AT yafengshang aclinicalstudyonminimallyinvasivepercutaneousnephrolithotomycombinedwithureteralaccesssheathforthetreatmentofkidneystones
AT boyangliu clinicalstudyonminimallyinvasivepercutaneousnephrolithotomycombinedwithureteralaccesssheathforthetreatmentofkidneystones
AT boyangliu clinicalstudyonminimallyinvasivepercutaneousnephrolithotomycombinedwithureteralaccesssheathforthetreatmentofkidneystones
AT yanjiekang clinicalstudyonminimallyinvasivepercutaneousnephrolithotomycombinedwithureteralaccesssheathforthetreatmentofkidneystones
AT yafengshang clinicalstudyonminimallyinvasivepercutaneousnephrolithotomycombinedwithureteralaccesssheathforthetreatmentofkidneystones